OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
πΊπΈUnited States
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
- First Posted Date
- 2010-06-23
- Last Posted Date
- 2015-04-02
- Target Recruit Count
- 252
- Registration Number
- NCT01149655
- Locations
- π¨π³
Study Site, Taoyuan County, Taiwan
Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive Disorder
Completed
- Conditions
- First Posted Date
- 2010-06-16
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 501
- Registration Number
- NCT01145313
The Effect of Patient Cost-Sharing on Antidepressant and Adjunctive Therapy Use
Completed
- Conditions
- First Posted Date
- 2010-06-10
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 48865
- Registration Number
- NCT01141400
Outcomes in MEasurement-Based Treatment
Completed
- Conditions
- First Posted Date
- 2010-06-10
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 914
- Registration Number
- NCT01141387
Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2010-05-26
- Last Posted Date
- 2021-11-11
- Target Recruit Count
- 10
- Registration Number
- NCT01131351
- Locations
- π±πΉ
Hospital for Tuberculosis and Lung Diseases, Siauliai, Lithuania
π±π»Infectology Center of Latvia - Clinic of Tuberculosis and Lung Diseases, Ogre, Latvia
π±πΉNational Tuberculosis and Infectious Diseases University Hospital, Vilnius, Lithuania
An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia
- First Posted Date
- 2010-05-25
- Last Posted Date
- 2020-01-06
- Target Recruit Count
- 709
- Registration Number
- NCT01129882
To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2010-05-14
- Last Posted Date
- 2021-12-22
- Target Recruit Count
- 173
- Registration Number
- NCT01123707
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2010-05-13
- Last Posted Date
- 2016-02-08
- Target Recruit Count
- 524
- Registration Number
- NCT01122927
- Locations
- πΊπ¦
Study Site, Vinnytsya, Ukraine
πΊπ¦Study Site 2, Kharkiv, Ukraine
πΊπ¦Study Site 1, Kharkiv, Ukraine
Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2010-04-27
- Last Posted Date
- 2021-10-26
- Target Recruit Count
- 237
- Registration Number
- NCT01111552
- Locations
- π·π΄
Study Site 1, Bucuresti, Romania
π·π΄Study Site 2, Bucuresti, Romania
Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2010-04-27
- Last Posted Date
- 2021-12-21
- Target Recruit Count
- 137
- Registration Number
- NCT01111565
- Locations
- πΏπ¦
Study Site 1, Cape Town, South Africa
πΏπ¦Study Site 2, Cape Town, South Africa
Β© Copyright 2024. All Rights Reserved by MedPath